GTransCYPs:一个改进的图形转换器神经网络,具有注意力聚合,可靠地预测CYP450抑制剂
Candra Zonyfar1, Soualihou Ngnamsie Njimbouom1, Sophia Mosalla2
1Department of Computer Science and Electronic Engineering, Sun Moon University, Asan, 31460, Republic of Korea.
Journal of cheminformatics
|October 30, 2024
概括
我们开发了一种新的图形神经网络模型GTransCYPs,以准确预测CYP450酶抑制剂. 这种先进的方法通过加强对关键CYP450异酶的抑制剂和非抑制剂的区分来改善早期药物发现.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 生物信息学是一种生物信息学.
背景情况:
- 预测P450 (CYP450) 酶抑制剂对早期药物发现至关重要.
- 目前用于in silico预测CYP450抑制剂的机器学习 (ML) 方法在准确性方面面临挑战.
研究的目的:
- 引入GTransCYPs,一个带有变压器机制的增强图形神经网络 (GNN) 模型.
- 提高CYP450抑制剂的预测准确度,特别是主要异酶 (1A2,2C9,2C19,2D6和3A4) 的预测.
主要方法:
- 开发了GTransCYPs,这是一个深度学习架构,将GNN与变压器机制和注意力聚合集成.
- 利用变压器卷积层进行特征处理和全球注意力聚合,用于图形级信息合成.
- 在CYP450预测任务上测试了四种GTransCYPs变异,使用不同的聚合技术.
主要成果:
- 与现有的最先进的方法相比,GTransCYPs在区分CYP450抑制剂和非抑制剂方面表现优异.
- 带有注意力聚合算法的图形变压器实现了最佳的预测性能.
- 实验和废除研究证实了该模型的有效性.
结论:
- GTransCYPs提供了一种具有成本效益和高效的计算方法,用于预测CYP450抑制.
- 拟议的深度学习模型显著提高了 in silico CYP450 抑制剂预测的准确性.
- 对于GTransCYPs的源代码是公开可用的,用于进一步的研究和应用.
相关概念视频
02:07Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
02:07Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...